Research
GLP-1s often contain untested additive combinations, study finds
The Brief
- Use of GLP-1 receptor agonist medications has risen sharply in recent years.
- Many people use compounded GLP-1 products, which combine a GLP-1 with other active substances.
- Some of the other substances in compounded products are not regulated by the FDA; a new study examined these combinations and reports that they are often untested.
Why it matters
Patients using compounded GLP-1 products may be taking combinations of ingredients that have not been tested together, so their safety and effects are less certain than for approved medicines.
Who’s affected
- people using or considering compounded GLP-1 products
- clinicians and pharmacists who prescribe or dispense GLP-1 medications
- #glp-1
- #compounded drugs
- #drug safety
- #fda regulation
- #medications
Use of GLP-1 receptor agonist medications (GLP-1s) has skyrocketed in recent years, and many people are using "compounded" GLP-1 products: medicines that include GLP-1s as well as other active substances, some of which are not regulated by the FDA. A new study found that…